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I. Induction of proteinuria in the rat by a monodonal antibody against
SGP-115/107. The role of individual antigenic determinants in the
pathogenesis of antibody-mediated glomerular injury is, at present,
incompletely understood. This study was designed to compare the
effect of monoclonal antibodies upon binding to three distinct antigenic
determinants present in the glomerular capillary wall. Ten monoclonal
antibodies were tested for their nephrotoxic capacity in the rat. Six
antibodies directed against basement membrane laminin and three
antibodies with specificity for a 129/117 kd antigenic complex present
on endothelial and glomerular visceral epithelial cell surfaces did not
induce proteinuria or structural injury. A non-complement binding
monoclonal antibody that immunoprecipitates a 115/107 kd sialo-glyco-
protein (SGP-l 15/107) from glomerular cell membrane preparations and
a 107 kd component from proximal tubules, intestinal cells and liver
cells, induces glomerular epithelial cell alterations consisting of focal
obliteration of foot process architecture, vacuolar changes in the
cytoplasm, microvillous transformation of the cell surface, and focal
retraction of podocytes, resulting in detachment of the epithelium from
the underlying basement membrane. These structural changes are
accompanied by immediate transient proteinuria only in animals given
complete Freund's adjuvant at the time of antibody administration.
These studies indicate that direct antibody-mediated glomerular injury
can be induced in the rat by administration of monoclonal antibodies
specific for cell associated antigens.
Anti-glomerular basement membrane disease, with its rapidly
progressive clinical course and proliferative and crescentic
morphologic expression, is the only renal disease in humans
believed to result from the interaction between circulating
antibodies and a fixed, intrinsic component of the glomerular
capillary wall. Recent studies have shown that the antigenic
determinant involved in this immune injury is the non-collag-
enous NCI portion of type IV collagen [I].
Our knowledge of the mechanisms responsible for this disor-
der has been derived principally from experimental studies
performed since the beginning of this century [2, 3] in labora-
tory animals by administration of heterologous antisera contain-
ing a mixture of antibodies with specificity for various matrix
and cell surface constituents of the glomerular capillary wall.
The role played by individual antigen-antibody systems in the
pathogenesis of the disease and its functional and structural
expression has received relatively little attention.
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Early studies performed with antisera against connective
tissue-rich antigenic mixtures derived from different organs
have clearly shown a variable nephrotoxic capacity of these
preparations [41; the nephrotoxicity of anti-kidney antibodies
was always remarkably higher when compared to antisera
raised against spleen, heart, or skeletal muscle constituents.
These studies strongly suggest that unique antigenic determi-
nants are present in the mixture obtained from the kidney. Such
antigens either are absent from the material extracted from the
other organs or present in vastly different concentrations,
which may explain the variable capacity to induce nephrotoxic
antibodies. The difference in proteinuria and glomerular hyper-
cellularity between the groups studied by Katz, Unanue and
Dixon [4] could not always be explained solely on the basis of
the amount of antibody bound to the target organ. Clearly,
various specific antigenic determinants must be involved in this
complex experimental immune process induced by passive
administration of the different antisera.
More recently, the limited capacity of antibodies directed
against purified basement membrane components to mimic the
full spectrum of manifestations of the human condition associ-
ated with circulating anti-glomerular basement membrane anti-
bodies has also become apparent through experimental studies
utilizing heterologous anti-collagen [51, anti-laminin [6, 7], and
anti-basement membrane proteoglycan antisera [8]. Collec-
tively, these studies suggest that the experimental model of
antiglomerular basement membrane disease is not the result of
the interaction of a single antigenic determinant with specific
antibodies, but rather the consequence of the binding of anti-
bodies to different antigens present at various levels within the
glomerular capillary wall.
In an effort to characterize the individual antigen-antibody
systems that participate in the induction of nephrotoxic serum
nephritis, we produced monoclonal antibodies in the mouse
with specificity for various constituents of the rat glomerular
capillary wall. In this paper, we present the results obtained in
the rat by passive administration of hybridoma-derived antibod-
ies directed at three different antigenic components of the
glomerular capillary wall. We describe a monoclonal antibody
capable of inducing significant proteinuria and morphologic
changes of the glomerular epithelial cells, characterized by
effacement of foot process architecture and focal detachment of
podocytes from the underlying basement membrane.
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Methods
Production of monoclonal antibodies
Monoclonal antibodies were produced as previously de-
scribed [9]. Briefly, BALB/c mice (Cumberland View Farms,
Clinton, Tennessee, USA) were immunized with a homogenate
of rat renal cortex emulsified in complete Freund's adjuvant
containing 5 mg/mI of H37 RA Mycobacterium tuberculosis
(Difco Laboratories, Detroit, Michigan, USA) and boosted with
this antigenic preparation in incomplete Freund's adjuvant
every two weeks. Spleen cells were fused with P3-NSl/l-Ag4-l
myeloma cells using 50% polyethylene glycol 1500 at a 4:1 ratio
of splenocytes to myeloma cells. Supernatants of growing
hybridomas were tested for anti-kidney activity by indirect
immunofluorescence microscopy on acetone fixed cryostat sec-
tions (4 m thick) of normal rat kidney. Selected hybridomas
were cloned in soft agar or by limiting dilution and re-tested by
indirect immunofluorescence microscopy.
Structural localization of antigens
Antigens recognized by the different monoclonal antibodies
were localized by indirect immunofluorescence microscopy on
acetone fixed frozen sections of normal rat tissues (kidney,
liver, spleen, lung, small intestine) and normal kidney tissue
from other species (mouse, rabbit, guinea pig, human).
Solubilization of antigens for immunoprecipitation
Kidney, liver and intestine of normal rats were perfused in
situ with cold (4°C) phosphate-buffered saline solution (PBS;
0.01 M phosphate buffer, pH 7.4, 0.15 M NaCI) containing 0.02%
sodium azide, 0.1 mi phenylmethyl-sulfonyl fluoride (Sigma
Chemical Co., St. Louis, Missouri, USA), and 0.5 mM dithio-
threitol (Sigma). The tissues were removed and subjected to the
following isolation procedures:
Glomeruli were isolated by sequential sieving and extracted
at room temperature, under constant agitation for one hour, as
a 10% vol/vol suspension in 1% vol/vol Nonidet 40 (NP-40;
Sigma) or 1% wtlvol Brij-35 (Sigma) dissolved in the perfusate
buffer. The preparation was then centrifuged for one hour at
25,000 g and the supernatant stored at —20°C until used.
Proximal tubule brush border antigen was prepared from
isolated vesicles obtained by the method of Booth and Kenney
[10] and subjected to the NP-40 detergent solubilization step as
described above.
Epithelial cells were isolated from the small intestine of the
rat following the method of Weiser [11]. Solubilization was
performed with NP-40 as described above.
The liver antigen was prepared in a manner similar to that of
the proximal tubule brush border antigen with the addition of a
sieving step following homogenization.
Glomerular basement membrane was obtained from sieve-
isolated glomeruli [12] and subjected to enzymatic digestion [13]
for 48 hours at 37°C with chromatographically-purified bacterial
collagenase (Cooper Biomedical Inc., Malvern, Pennsylvania,
USA) [14]. The antigen preparation was then centrifuged at
25,000 g for one hour and stored at —20°C until used. Protein
content of the solubilized material was determined by a modi-
fication of the Lowry technique [15].
Radiolabeling of antigens
Solubilized antigens were labeled with 1251 (New England
Nuclear, Boston, Massachusetts, USA) using lodobeads (Pierce
Chemical Co., Rockford, Illinois, USA) [16] and following the
manufacturer's instruction. Alternatively, cell surface sialo-
glycoproteins were labeled with NaB3H4 (New England Nu-
clear) following a modification of the technique described by
Gahmberg and Anderson [17]. Briefly, sodium metaperiodate
was added to 1 mg of solubilized protein to obtain a I m final
concentration, and the solution was incubated for 10 minutes on
ice. Glycerol was added at a final concentration of 25 m and
the solution dialyzed overnight at 4°C against PBS containing
0.02% sodium azide. The material was removed from dialysis
and reacted with 2 mCi of NaB3H4 for 30 minutes at room
temperature. Non-tritiated sodium borohydride was then added
(2 mg), and the solution was exhaustively dialyzed against PBS
containing 0.02% sodium azide.
Immunoprecipitation of antigens
The radiolabeled antigen preparations were preadsorbed with
rabbit anti-mouse immunoglobulin and formalin-fixed Staphy-
lococcus aureus bacteria (IgGSORB, The Enzyme Center, Inc.,
MaIden, Massachusetts, USA) precoated with bovine serum
albumin. The preadsorbed antigen was then incubated with 100
pi of cloned hybridoma supernatant for one hour at room
temperature. Affinity-purified rabbit anti-mouse immunoglobu-
lin was added and the incubation continued for another hour, at
which time 100 /.Li ofa 10% vol/vol suspension of Staphylococ-
cus aureus bacteria was added. Following a one hour incuba-
tion, the mixture was centrifuged and the pellet washed six
times with PBS containing 0.01% sodium dodecyl sulfate (SDS).
Immunoprecipitated antigens were then solubilized by boiling
for five minutes in sample buffer according to Laemmli [18].
Samples and standards of known molecular weights (Bio-Rad)
were then subjected to discontinuous SDS gel electrophoresis
on 5 to 15% polyacrylamide gradient gels.
Molecular weight standards were visualized with a Coomas-
sie Blue stain (Bio-Rad). The gels were destained and dried.
Gels containing beta-emitters (3H) were impregnated with Au-
tofluor (National Diagnostics, Sommerville, New Jersey, USA)
before drying. Direct and indirect autoradiography [19, 20] were
performed at —70°C using pre-exposed Kodak X-OMAT film
(Eastman Kodak Co., Rochester, New York, USA). Cronex
Lightning Plus intensifying screens (E. I. Dupont De Nemours
and Co., Wilmington, Delaware, USA) were utilized to inten-
sify the images obtained from gels that contained 1251. The
molecular weight of immunoprecipitated antigens was then
calculated from their relative mobilities utilizing, as reference,
the relative mobilities of the standard proteins of known mo-
lecular weights.
Immunoblotting technique
Isolated glomeruli or proximal tubule brush border vesicles
were solubilized in Laemmli's sample buffer and electropho-
resed on S to 15% gradient gels as described above. Protein
bands were transferred to nitrocellulose sheets (Millipore Cor-
poration, Bedford, Massachusetts, USA) by electrophoretic
transblotting for 24 hours following the procedure described by
Towbin, Staehelin and Gordon [21]. The protein binding capac-
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Table 1. Experimental groups
Concomitant Period of
Dose of mAb immunization and observation
mg route days
Group 1 66 0.2 ml CFA+lgG/s.c. 34
Group 2 10 0.2 ml CFA+lgG/s.c. 2
Group 3 10 0.2 ml IFA+LgG/s.c. 2
Group 4 10 2.0 ml CFA+lgG/i.p. 7
Abbreviation is: mAb, monoclonal antibody.
ity of the nitrocellulose paper was then saturated by incubation
in 1% bovine serum albumin in PBS containing 0.02% sodium
azide. Strips of nitrocellulose paper were exposed to various
hybridoma supernatants, washed and then incubated with 125l
labeled, affinity-purified rabbit anti-mouse immunoglobulin. The
radioactive bands were revealed following direct and indirect
autoradiography as described above.
Characteristics of antibodies
Class and subclass of individual antibodies were determined
by double immunodiffusion using commercially obtained spe-
cific antisera (Miles Laboratories, Elkhart, Indiana, USA).
The isoelectric points of hybridoma-derived antibodies were
determined by isoelectric-focusing on horizontal slab acryl-
amide gels containing 4.5 g/l0O ml of acrylamide/bis-acrylamide
(Bio-Rad), 4 g/lOO ml glycerol and I g/100 ml ampholytes (LKB
Produkter, Bromma, Sweden). Polymerization was achieved on
silane-coated glass plates by ammonium sulfate and TEMED
(Bio-Rad). Radioactive labeling of the antibodies was accom-
plished by 35S-methionine incorporation. For this purpose, 1.5
x 106 hybrid cells were placed in 1 ml of methionine-free RPMI
1640 (15! Biologicals, Gary, Indiana, USA) supplemented with
L-glutamine, sodium pyruvate, Hepes buffer, 10% (vol/vol)
decomplemented fetal calf serum, 20% (vol/vol) methionine-
containing culture medium, and 50 Ci of 35S-methionine (New
England Nuclear). Supernatants were harvested after 18 to 24
hours, dialyzed against distilled water for 48 hours, aliquoted,
and frozen until used. Samples containing iO cpm were loaded
on preformed wells in the acrylamide gel. Electrofocusing was
performed at a constant current/voltage of 1 mAmp/band and
300 volts for 4.5 hours at 4°C. At the end of the electrophoretic
procedure the pH on the gel was measured at 0.5cm intervals
with a surface microelectrode. The gel was stained with Coo-
massie blue R250 (Bio-Rad), destained in methanol/acetic acid/
water mixture (4:1:5), and dried on the glass at room temper-
ature. Autoradiography was performed by exposure to Kodak
X-OMAT AR film as described above.
The ability of monoclonal antibodies to bind complement in
vitro was assessed by an immunofluorescence assay [22]. For
this purpose, 4 sm-thick frozen sections of normal rat kidney
were fixed for 10 minutes at room temperature in anhydrous
ether:alcohol (1:1, vol/vol), washed in PBS, and incubated for
30 minutes at room temperature with a hybridoma supernatant.
The sections were then washed and incubated for 30 minutes at
25°C with fresh human serum diluted 1: 10 vol/vol in sodium
barbital buffer/salt solution (0.005 M barbital, 0.142 M sodium
chloride, 0.15 m calcium chloride, 0.5 m magnesium chlo-
ride, pH 7.35). Bound complement was visualized on sections
Table 2. Characteristics of monoclonal antibodies
In vitro
Antibody Specificity Class p1 C-binding
K9/9 Epithelial cells IgG1 6.6; 6.8 Negative
K12/5 Basement
membrane
IgG1 8.2; 8.4; 8.6 Negative
K12/8 Basement
membrane
IgG1 5.3; 5.5 Negative
K23/2 Basement
membrane
lgG1 ND Negative
K23/3 Basement
membrane
IgG1 ND Negative
K23/7 Basement
membrane
lgG1 ND Negative
K23/9 Basement
membrane
IgG1 ND Negative
K6/l Endothelial and
epithelial cells
LgG2 8.0; 8.1; 8.3 Negative
K 10/2 Endothelial and
epithelial cells
IgG2b ND Negative
K6/3 Endothelial and
epithelial cells
IgG1 4.7 Negative
Kl6/l6 Non-specific IgG1 6.2; 6.5 ND
Abbreviation is: ND, not determined
with fluorescein-conjugated goat anti-human C3 (Cooper Bio-
medical) previously adsorbed with mouse liver powder (Pel-
Freez Biologicals, Roberts, Arkansas, USA). Positive and
negative control sections were incubated simultaneously with
kidney-binding monoclonal antibodies belonging to subclasses
with variable capacities to activate the complement cascade
[23].
Animal experiments
Female Lewis rats (125 to 150 g) were obtained from Charles
River Breeding Laboratories (Wilmington, Massachusetts, USA).
All monoclonal antibodies utilized for in vivo experiments
were produced as ascitic fluid in mice primed with 2, 6, 10,
14-tetramethylpentadecane (Aldrich Chemical Company, Mil-
waukee, Wisconsin, USA). Ascitic fluid was subjected to a 45%
ammonium sulfate precipitation, and the resulting immunoglob-
ulin fraction was dialyzed against PBS for two to three days and
against saline for one day.
Normal female Lewis rats were used for all animal studies.
The initial experiments (Group I animals; Table I) were per-
formed by intravenous administration of 66 mg of ascites-
derived immunoglobulin fraction containing any of the mono-
clonal antibodies listed in Table 2. These animals also received
a single concomitant subcutaneous injection of 0.2 ml of com-
plete Freund's adjuvant prepared as a mixture of 50% vol/vol
incomplete Freund's adjuvant, 50% vol/vol ascites-derived im-
munoglobulin fraction containing 10 mg/mI of protein, and 5
mg/ml H37RA Mycobacterium tuberculosis (Difco Laborato-
ries). Since preliminary dose response experiments had sug-
gested that 66 mg of the immunoglobulin preparation was
excessive, we reduced the amount of injected monoclonal
antibodies to 10 mg in Group 2 animals. These rats also received
the immunization with complete Freund's adjuvant described
for Group 1. The permissive effect of complete adjuvant admin-
istration on the expression of the disease was controlled in
Mendrick and Rennke: Antibody-mediated glomerular cell injury 821
Fig. 1. Distribution of K9/9 antigen in rat kidney (A) and liver (B) as revealed by indirect immunofluorescence microscopy. A. There is diffuse and
regular binding of the monoclonal antibody to brush border microvilli of proximal convoluted tubules and irregular, coarse staining of the
glomerular capillary wall (x 185). B. The antigen is present on bile canaliculi of hepatocytes and on the luminal surface of bile ducts (x 185).
Group 3 animals, which received 10 mg of the monoclonal
antibody preparation and were immunized with 0.2 ml of
incomplete Freund's adjuvant, containing 10 mg/mI of ascites
derived, non-kidney-binding immunoglobulin. Group 4 con-
sisted of animals pre-immunized by intraperitoneal administra-
tion of 2 ml of complete Freund's adjuvant [241 followed at day
14 by an intravenous injection of 10 mg of K9/9 containing
ascitic immunoglobulin.
Animals in Group I were studied for up to 34 days, those in
Groups 2 and 3 were followed for 48 hours, and those in Group
4 were studied for a total of seven days following the antibody
injection.
The disappearance of the administered kidney-binding anti-
body from the circulation was monitored by indirect immuno-
fluorescence microscopy. Sera were obtained from rats at
various time intervals from tail vein blood and used undiluted
on cryostat sections of normal renal tissue. The second reagent
consisted of fluorescein conjugated, affinity-purified rabbit anti-
mouse immunoglobulin. The presence of circulating rat anti-
mouse IgG antibodies was detected by double diffusion in agar
using normal mouse sera as the antigen.
Rats were housed in metabolic cages with free access to food
and water, and the urine was collected daily. Urinary protein
levels were determined by the sulfosalicylic acid precipitation
method [25] using Lab-Trol (Dade Diagnostics, Aguada, Puerto
Rico) as protein standards in concentrations ranging from 0 to I
mg/mI. Urinary protein was further analyzed by SDS polyacryl-
amide gel electrophoresis following a trichloroacetic acid pre-
cipitation step. The presence of hematuria was assessed using
Bili-Labstix (Miles Laboratories),
Morphologic studies
For these studies, the right kidney of the experimental
animals was removed under pentobarbital anesthesia. Coronal
sections were either placed in 10% formalin for light micro-
scopic examination or snap frozen in liquid nitrogen for immu-
nofluorescence microscopy. Blood was obtained at this time to
determine the persistence in circulation of the administered
antibody as described above. The left kidney was then perfused
in situ with 1.25% glutaraldehyde in 0.1 M sodium cacodylate
buffer, pH 7.4, and processed for light and electron microscopy
through epoxy resin embedding as previously described [161.
Two to four glomeruli per animal were randomly selected for
ultrastructural analysis.
Frozen sections cut at 4 tm thickness from the right kidney
were processed (unfixed) for direct immunofluorescence mi-
croscopy using fluorescein conjugated, affinity-purified rabbit
anti-mouse immunoglobulin, affinity-purified rabbit anti-rat im-
munoglobulin, and goat anti-rat C3. Coronal sections of the
formalin-fixed (right) kidney and the perfusion-fixed (left) kid-
ney were dehydrated, embedded in paraffin, sectioned at 3 sm
thickness, stained with hematoxylin/eosin or periodic acid-
Schiff reagent (PAS), and examined for hypercellularity and
structural abnormalities.
Quantification of antibody binding
Immunoglobulin fractions of ascites were trace labeled with
1251 using the Chloramine T method [26]. Unbound 1251 was
removed from the preparation by G-25 Sepharose column
chromatography and the percent of protein bound radioactivity
determined by trichloroacetic acid precipitation.
Each animal used in these studies received an intravenous
injection of 10 mg of immunoglobulin containing 106 cpm of
trace-labeled '251-immunoglobulin. Some of these animals were
also given a subcutaneous injection of 0.2 ml complete or
incomplete Freund's adjuvant as described above.
Twenty-four hours later, the right kidney was removed under
anesthesia and processed for morphologic studies as described
above. Blood was obtained to assess the level of mouse
immunoglobulin in the circulation. The left kidney was then
ISese a
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Fig. 2. Immunoprecipitatwn ofK9/9 antigen rom non-ionic detergent-
salubilized cell membrane preparations, labeled wit/I 125j Lane I =
glomerular preparation, lane 2 = proximal tubule brush border fraction,
lane 3 = intestinal mucosa cell membrane preparation, lane 4 = liver
cell member preparation, lane 5 = glomerular preparation immunopre-
cipitated with 1(16/16, a non-binding monoclonal antibody of the IgGi
subclass. The antibody specifically precipitates a polypeptide with
apparent molecular weight of 107 kd. An additional faint band of
apparent molecular weight of 115 kd is present in the glomerular
preparation, lane 1. The major antigen immunoprecipitated from the
liver cell membrane preparation shown in lane 4 has a slightly slower
relative mobility in the gel; in addition, two smaller peptides of apparent
molecular weight of 59 and 32 kd are also identified. (SDS-PAGE
followed by direct and indirect autoradiography).
perfused in situ with PBS, freed from connective tissue, and
counted for radioactivity in a Beckman gamma counter (Beck-
man Instruments, Inc., Irvine, California, USA). The amount of
kidney-bound immunoglobulin was expressed as sg of immu-
noglobulin per two kidneys. The amount of glomerular-bound
immunoglobulin was determined by the method described by
Salant, Darhy and Couser [27]. Briefly, sieve isolated glomeruli
were counted numerically and their isotope content determined
as described above. The radioactivity was then normalized.
assuming a total count of 76,000 nephrons per animal [27]. The
amount of immunoglobulin bound to all glomeruli was then
calculated from the specific activity of the injected preparation
and the isotope concentration measured in isolated glomeruli.
Results
Localization and biochemical characterization of glomerular
antigens
Monoclonal antibody K9/9 recognizes antigen(s) present in
the glomerular capillary wall, on the brush border membrane of
both the renal proximal tubule and the small intestine, on the
surface of bile canaliculi in liver cells, on the luminal side of bile
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Fig. 3. Western blot analysis of SDS—soluhilized glo,nerular (lanes I and
2) and proximal tubule brush border (lane 3) preparations. Nitrocellu—
lose strips in lane I and 3 were incubated with monoclonal antibody
K919, lane 2 illustrates the control incubation with Kl6/l6. Bound
mouse immunoglobulin was detected by '251-laheled, affinity-purified
rabbit anti-mouse lgG. (Western blot followed by direct and indirect
autoradiography)
ducts, and on the venules of the spleen (Fig. 1). This monoclo-
nal antibody specifically immunoprecipitates two peptides from
the NP-40 or Brij-35 glomerular antigen preparation, a minor
component with apparent molecular weight of 115 kd and a
major band of 107 kd (Fig. 2). Similar bands also immunopre-
cipitate from Brij-35 glomerular antigens labeled with tritiated
sodium borohydride. Only the lower molecular weight peptide
was immunoprecipitated from the proximal tubule brush bor-
der, the intestinal epithelium, and the liver cell membrane
preparations. The antigen isolated from the liver preparation
has a slightly slower relative mobility when compared to the
peptides isolated from the other epithelia when electrophoresed
on the same gel (Fig. 2). The precise nature of this difference is
unknown, but it likely represents differences in the degree of
glycosylation of the membrane-associated proteins in the vari-
ous organs. l'wo additional smaller peptides were identified in
the liver cell preparation with apparent molecular weights of 59
and 32 kd.
Similar molecular weight estimates were obtained from West-
ern blot analysis on glomerular and proximal tubule brush
border antigen preparations with antibody K919. While a double
band was identified in the transblot of glomerular antigens, only
the 107 kd band was present on immunoblots of renal proximal
tubule brush border vesicle preparations (Fig. 3). The relative
intensity of the upper hand varied somewhat from one antigenic
preparation to another, a phenomenon probably related to the
degree of contamination of the preparation of isolated glomeruli
with proximal tubule fragments.
To control for the effect of antibody binding to matrix
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Fig. 4. Distribution of the antigen recognized by monoclonal antibody
K12/8. There is a linear distribution of the antibody along the glomerular
and tubule basement membranes. Vascular basement membranes (not
illustrated) were likewise positive. (Indirect immunofluorescence on
normal rat renal cortex, x 580)
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Fig. 5. linmunoprecipilation of '25!-lahe!ed glomerular basement ,ne,n-
brane antigens solubi/ized will? co/lagenase. Lane I (K 16/16, a control
monoclonal antibody) does not show specific protein bands. Lane 2
(K12/8) and lane 3 (K12/5) revealed peptides of apparent molecular
weights of 220 and 98 kd. These monoclonal antibodies also precipitate
larger peptides that remain at the origin of the 5% acrylaniide gel. Three
peptide bands with identical relative mobilities were identified by an
affinity-purified polyclonal rabbit, anti-laminin antibody preparation.
(SDS-PAGE followed by direct and indirect autoradiography).
components of the glomerulus, we chose a series of six different
anti-laminin antibodies. These antibodies include K12/5, K 12/8,
K23/2, K23/3, K23/7, and K23/9. As described previously [9],
Fig. 6. Distribution of antigen recognized by monoclonal antibody K6/1.
There is diffuse, coarse deposition of the mouse immunoglobulin along
the glomerular capillary wall. Note the binding to endothelium of
peritubular capillaries. The binding pattern is characteristic for a
cell-associated antigen. (Indirect immunofluorescence microscopy on
normal rat cortex, X 580).
these antibodies bind to vascular and epithelial basement mem-
branes in the kidney (Fig. 4) and other tissues of the rat. These
monoclonal antibodies immunoprecipitate peptides with appar-
ent molecular weights of 220 kd and 98 kd from collagenase-
solubilized GBM preparations (Fig. 5). Such immunoprecipi-
tates invariably showed high molecular weight components as
well, which barely penetrated the 5% acrylamide gel. Peptides
of identical molecular weights were identified in collagenase-
solubilized glomerular basement membrane preparations by
immunoprecipitation with purified rabbit anti-laminin immuno-
globulin.
A third set of three monoclonal antibodies used for in vivo
administration (Kb/I, K1O/2, and K6/3) recognize cell surface
determinants present within the GCW, including antigens pres-
ent on endothelial and glomerular epithelial cell surfaces and in
the matrix of the glomerular basement membrane. The antigen
is also present on the cell surface of peritubular capillaries (Fig.
6) and other capillaries of rat tissues. These monoclonal anti-
bodies were used to control the effect of antibody binding to cell
surface components of the glomerular capillary wall. These
monoclonal antibodies specifically immunoprecipitate two bands
with apparent molecular weights of 129 and 117 kd from
glomerular antigen preparations extracted with NP-40 or Brij
35. The antigen is solubilized particularly well in Brij 35 and can
be immunoprecipitated from this preparation with either of the
three monoclonal antibodies (Fig. 7). A third glycopeptide with
an apparent molecular weight of 107 kd is also recognized when
the extracted antigens, labeled with 3H, are immunoprecipi-
tated with these antibodies, or when Western blots of SDS-
extracted glomeruli are reacted with these antibodies.
None of the antibodies mentioned above recognizes determi-
'I
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Fig. 7. Immunoprecipitation of '251-labeled glomerular antigen prepa-
ration with monoclonal antibodies K6/1 (lane 1) and the non-binding
K16/16 (lane 2). Two peptides with apparent molecular weights of 129
and 117 kd are precipitated specifically by this antibody. (SDS-PAGE
followed by direct and indirect autoradiography).
Fig. 8. Urinaryprotein excretion profile of animals receiving 66 mg of
ascites-derived monoclonal antibodies. Open circles represent mean
values obtained in 5 animals receiving K9/9; closed circles represent
average values obtained in all other animals (N = 30) receiving
monoclonal antibodies directed against laminin, against the 129/117 kd
cell surface associated glomerular antigen, or K 16/16, the non-binding
monoclonal antibody. T bars represent standard deviations.
nants present in human, guinea pig, rabbit or mouse kidney and
should therefore be considered species specific for the rat.
An antibody without specificity for rat tissues, K 16/16, was
used as a control in immunoprecipitation, transblotting, and all
animal experiments.
Characteristics of monoclona! antibodies
All antibodies listed above belong to the IgG1 subclass with
the exception of K6/l and K10/2, which react for IgG2a and
IgG2 specificities, respectively. The isoelectric points and
other characteristics of the antibodies used in these expen-
ments are listed in Table 2. Up to three distinct isomers were
detected in individual preparations of monoclonal antibodies on
the autoradiographs of the isoelectric focusing gels. All these
antibodies proved to be noncomplement fixing, as determined
by the in vitro immunofluorescence assay utilizing a source of
human complement and fluorescein isothiocyanate-labeled anti-
human C3.
Disease induction in rats
Urinary protein excretion data obtained in Group 1 animals
are depicted in Figure 8. Animals that were injected with
monoclonal antibody K9/9 developed significant proteinuria,
lasting six to eight days. The permeability defect was judged
non-selective since both albumin and immunoglobulins were
demonstrable in the urine by SDS polyacrylamide gel electro-
phoresis. The protein excretion rate peaked on day 2 with
average values reaching 63 mg/24 hrs, followed by a gradual
decline and virtual normalization by day 10. Groups of three
Fig. 9.Binding of monoclonal antibody K9/9 to renal cortical structures
24 hrs following in vivo administration of 66 mg of ascites derived
immunoglobulin preparation. The antibody binds diffusely to the gb-
merular capillary wall, the proximal tubule brush border, and faintly
along the tubular basement membrane. Proximal tubule structures were
positive for mouse immunoglobulins only in proteinuric animals that
received complete Freund's adjuvant. (Direct immunofluorescence
microscopy, x 540).
animals were injected with any of six anti-laminin antibodies,
any of the three antibodies directed against the 129/117 kd
glomerular cell surface antigen, or K16/l6, the antibody without
kd 1 2
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Fig. 10. Ultrastructural alterations in a glomerulus of a proteinuric animal 24 hrs following K9/9 administration. Epithelial cells show prominent
vacuolar changes (V), an increase in the number of reabsorption droplets, microvillous transformation of the cell surface, and retraction of the
epithelial cell (asterisk) with separation from the basement membrane. There are no significant changes in the remaining structures of the
glomerulus. (CL capillary lumen; US = urinary space; x 3000).
kidney-binding specificity. The average protein excretion rate
in these animals was not altered appreciably from pre-injection
values, as depicted in Figure 8.
Animals injected with 10 mg of K9/9-containing ascites im-
munoglobulin (Group 2) also developed abnormal urinary pro-
tein excretion with an average value of 32 mg/24 hrs during the
first day post-injection and returning to baseline values within
five days. Animals that received any of the other monoclonal
antibodies in similar doses did not develop an increase in the
rate of urinary protein excretion, with individual values never
exceeding 5 mg!24 hrs.
The proteinuric response was completely abrogated when the
Mycobacterium tuberculosis was omitted (Group 3 animals
immunized with incomplete Freund's adjuvant on the day of
antibody injection) or when the immunization with complete
Freund's adjuvant was performed 14 days prior to the admin-
istration of the monoclonal antibody (Group 4). None of the
animals in any of the groups in this study developed detectable
hematuria.
Structural alterations
Immunofluorescence studies performed on the kidneys of
rats injected with K9/9 containing ascitic protein revealed a
diffuse pattern of mouse immunoglobulin deposition in glomer-
uli at four hours after administration of the antibody. At 24
hours following the onset of proteinuria, mouse immunoglobu-
lin was visible in a diffuse, finely granular pattern within the
glomerular capillary wall, bound focally to the proximal tubule
brush border and occasionally along the tubular basement
membrane (Fig. 9). However, no rat immunoglobulin or C3 was
detected at any time interval. The pattern of antibody deposi-
tion was similar in rats receiving either 10 (group 2 animals) or
66 mg (group 1 animals) of K919 ascitic protein. Rats injected
with the high dose of antibody no longer exhibited significant
amounts of the mouse immunoglobulin within the kidney when
examined at day 10.
Light microscopic examination of the kidneys of rats injected
with K9/9 twenty-four to forty-eight hours before sacrifice
,
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Fig. 11. Details oft/ic glomerular epithelial cell abnormalities fhllowing K9/9 administration. A. The epithelial cell shows numerous vacuoles (V)
and electron dense reabsorption droplets. In addition there is focal obliteration of epithelial foot processes covering the capillary in the upper right
corner of the micrograph. Such changes were observed in both proteinuric and non-proteinuric animals. (CL = capillary lumen; x 4600). B. The
glomerular visceral epithelial cell has retracted and separated from the underlying basement membrane (arrows), leaving areas of the peripheral
capillary wall denuded of epithelial cover. Such defects were observed in virtually every glomerulus of proteinuric animals, but were absent in
non-proteinuric animals that received K9/9 and a simultaneous administration of incomplete Freund's adjuvant. (CL = capillary lumen; M
mesangium; x 4100).
revealed normal cellularity of glomeruli and absence of inter-
stitial inflammation. tiltrastructural analysis revealed diffuse
visceral epithelial cell damage as characterized by the formation
of large pockets of proteinaceous material within the epithelial
cell, increased number of lysosomes, focal obliteration and
retraction of podocytes and diffuse cell surface microvillous
degeneration (Figs. 10 and 11). Focal areas of the glomerular
capillary wall showed denudation of the basement membrane
due to epithelial cell retraction and detachment. Such defects
were also found over mesangial and paramesangial areas of the
capillary wall (Fig. IIB). Occasionally, detachment of glomer-
ular endothelial cells was also observed, as well as rare focal
loss of tubular brush border. No electron dense deposits were
detected either in the glomerular capillary wall, mesangial
areas, or along the tubular basement membranes. Six rats
injected with 10mg of K919 containing ascitic protein and which
received a footpad injection of incomplete Freund's adjuvant
(Group 3) exhibited binding of mouse immunoglobulin along the
glomerular capillary wall and on focal areas of proximal brush
border, but demonstrated no proteinuria. Although these ani-
mals showed some of the glomerular ultrastructural changes
observed in proteinuric rats that had received the complete
Freund's adjuvant, retraction of epithelial cells with separation
from the basement membrane was not seen in this group.
Animals injected with antibodies against laminin or against
the 129/117 kd glomerular cell surface antigen did not develop
any structural abnormalities, despite specific binding of the
mouse immunoglobulins during the heterologous phase of the
experiment. By days 10 to 15, well within the autologous phase,
there was binding of rat immunoglobulin to various cortical
structures, including the glomerular capillary wall, but no
proteinuria developed at this time in this group of animals (Fig.
8), nor were there any structural alterations present at the light
bound mAb
to bound to
Time kidneys glomeruli
hours g±sD g±sD
and electron microscopic level. Likewise, animals that received
the control K16/l6 monoclonal antibody did not manifest gb-
merular dysfunction or structural injury.
All animals that received 10 mg of K9/9-containing ascites-
derived immunoglobulin had detectable levels of the mouse
antibody in their circulation during the first 24-hour period, The
antibody was no longer detectable in circulation at day 6 in rats
which received the higher dose of 66 mg of the antibody
preparation. In contrast, some animals which received similar
doses of other kidney-binding antibodies had circulating mouse
antibodies for up to 23 days.
The amount of immunoglobulin bound to both kidneys, and
specifically, the glomerular-bound fraction, was measured in
rats which had received 10 mg of a monoclonal antibody
preparation (Table 3). Animals injected with the monoclonal
antibody K9/9 received either complete or incomplete Freund's
adjuvant. The omission of the Mycobacterium tuberculosis did
Table 3. Binding of monoclonal antibodies
mAb
Dose
Injection N mg
K9/9 + CFA 7 10
K9/9 + IFA 4 10
K12/8 + CFA 3 10
K6/l + CFA 3 10
K16/16 + CFA 2 10
24 40±4.7
24 32±5.6
24 64±2.6
24 51±1.0
24 10±2.6
15 5.3
14 5.9
14 12.5
33 7.5
2.7"
a Corrected, assuming 76,000 glomeruli/2 kidneys
"Two measurements available with values of 1.9 and 3.4 tg
Abbreviations are: mAb, monoclonal antibody; CFA, complete
Freund's adjuvant; IFA, incomplete Freund's adjuvant.
CL
CL
p
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not significantly affect the amount of glomerular bound immu-
noglobulin (15 pg vs. 14 pg). Note that animals injected with
either K6/l or K12/8 containing ascitic fluid exhibited on
average more kidney-bound mouse immunoglobulin (51 j.tg and
64 gig, respectively) than animals which had received K9/9 and
CFA (40 pg). Since all of these monoclonal antibodies also bind
to extraglomerular structures within the kidney, we measured
the level of glomerular bound immunoglobulin. Rats which
were injected with K6/l antibody exhibited more glomerular
bound immunoglobulin than those injected with K9/9 (33 ig vs.
15 pg), while animals receiving the anti-laminin K 12/8 exhibited
equivalent amounts of glomerular bound immunoglobulin when
compared to animals that received antibody K9/9.
Discussion
In this report we describe a monoclonal antibody directed
against a novel epithelial antigenic constituent capable of induc-
ing functional and structural abnormalities in glomeruli of the
rat upon in vivo binding. The antigen is present on epithelial
cells of various organs, has an apparent molecular weight of 115
and 107 kd, and appears to contain sialic acid residues [17]. We
would like to identify this antigen as sialo-glycoprotein 115/107
(SGP-l 15/107).
The obliteration and retraction of glomerular epithelial foot
processes and the abnormality in the permeability characteris-
tics that result from the binding of monoclonal antibody K9/9 to
SGP-l 15/107 occur without the interaction of the complement
system and without the participation of inflammatory cells,
since neither rat C3 nor leukocytes or macrophages were
detected in glomeruli of proteinuric animals. The absence of
such mediators of inflammation is also consistent with the
notion that murine IgG1 antibodies do not activate complement
[23]. Furthermore, given the relatively low affinity of the
immunoglobulin receptor of macrophages for this subclass of
antibodies, this IgG1 monoclonal antibody bound to its target
antigen may be of little significance for a possible antibody
dependent cellular cytotoxicity [28].
The capacity of anti-kidney antisera to directly induce per-
meability changes in the glomerulus, in the absence of comple-
ment activation and inflammatory cell infiltration, has been
demonstrated in several experimental models utilizing avian
anti-GBM antibodies [29, 30], and heterologous or autologous
mammalian antibodies or F(ab')2 fragments without comple-
ment-activating capacity in the host animal [3 1—37]. Moreover,
Couser et al [38] recently reported marked proteinuria in the
complement-depleted rat following sheep anti-rat GBM anti-
body administration (140 49 mg124 hrs in the cobra venom
factor treated animals vs. 217 71 mg/24 hrs in the control
rats). The permeability changes reported by these authors were
associated with focal obliteration of foot processes; however,
lifting of epithelial cells were not documented. The time course
of the permeability abnormality in unilaterally nephrectomized
and complement-depleted rats [38] was virtually identical to
that seen in the isolated perfused kidney exposed to a similar
dose of sheep anti-GBM antibodies. Although the authors
speculate that the permeability changes resulted from an alter-
ation in the internal geometry of the basement membrane upon
binding of the antibodies [381, a direct effect of antibodies on the
glomerular visceral epithelial cell appears to be a very attractive
alternative explanation. Such a direct effect, similar in nature to
that observed by us following administration of monoclonal
antibody K9/9, is likely to have occurred in the isolated
perfused kidney, particularly when one considers that sheep
antisera against whole lyophilized rat glomeruli were utilized in
the studies reported by Couser et al [38]. A complement- and
cell-independent mechanism of glomerular injury in the rabbit
model of anti-GBM disease was also demonstrated by Boyce
and Holdsworth, who reported that dual complement- and
leukocyte-depletion resulted in protein excretion rates similar
to those observed in the intact animals when a slightly higher
dose of nephrotoxic serum was administered [39].
The alterations induced by K9/9 upon binding to the cell
surface are antigen-specific since three monoclonal antibodies
specific for a different, cell associated 129/117 kd antigenic
complex, and five different anti-laminin monoclonal antibodies
do not induce such changes when administered in a sixfold
higher dose. Ultrastructurally-discernible immune deposits did
not develop in any of the experimental groups. The lack of
nephrotoxicity of our anti-laminin monoclonal antibodies and
the relatively mild disease induced by other investigators in the
rat during the heterologous phase following administration of
polyclonal antibodies directed at various basement membrane
matrix components [4—8] also suggest that cell-associated anti-
gens are likely to represent a more effective target for the
immunological damage seen in nephrotoxic serum nephritis.
Our findings also suggest that the binding of monoclonal
antibody K9/9 to SGP-l 15/107 is sufficient to induce ultrastruc-
tural alterations in the glomerular epithelial cells. However, the
abnormality in the sieving properties of the glomerular capillary
wall requires, for its full expression, a non-selective activation
of the immune system, as elicited by immunization with com-
plete Freund's adjuvant, or a functional state induced by such
activation. A potentiating effect of adjuvant administration was
also reported earlier in the rat with nephrotoxic serum nephritis
[24], autologous or homologous antibody-mediated thyroiditis
[40], and autoimmune orchitis [41]. The exact nature of the
synergism between K9/9 and complete Freund's adjuvant has
not been elucidated. Our antibody-binding studies suggest that
the effect of the adjuvant is not simply due to an increase in the
number of antigenic sites recognized by K9/9. It is conceivable,
however, that the activation of macrophages and lymphocytes
through their secretory products led to subtle structural, func-
tional, or biochemical changes of the cellular components of the
capillary wall that resulted in overt glomerular injury only upon
binding of the monoclonal antibody to its specific antigen.
Recent cell culture studies have demonstrated a profound
modulating effect of lymphokines and monokines on the struc-
ture and function of endothelial cells. Thus, interleukin-I (IL-I),
tumor necrosis factor (TNF), and immune interferon (IFN-y)
induce structural changes in cultured endothelial cells [42—44]
and increase the cell surface expression of an intercellular
adherence molecule on these cells [45—47]. Such adherence
molecules are believed to have a role in immune and inflamma-
tory responses in tissues. Only IL-I and TNF, but not IFN-y,
have been reported to induce on endothelial cells a procoagu-
lant activity [48—49], the expression of an endothelial cell
specific activation antigen [50], and an increased capacity for
neutrophil adhesion [5 1—521. Only IFN-y and TNF induce an
increase in HLA-A,B antigens [45, 53], while the induction in
endothelial cells of class II major histocompatibility complex
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antigens (HLA-DR, -DP, and -DQ), which confer to the endo-
thelium the capacity for antigen presentation, is achieved only
with IFN-y [54—56]. The effect of these immune mediators on
epithelial cells, however, is less well established. While IL-I
increases collagen type IV production in mammary epithelial
cells [57], IFN-y has been shown to induce HLA-DR antigen
expression in cultured human endometrial epithelial cells [58],
thyroid epithelial cells [59], epidermal keratinocytes [60, 611,
and renal tubule epithelial cells [62]. Although a direct effect of
such immune mediators on biochemical, structural, or func-
tional parameters of glomerular visceral epithelial cells is un-
known, the present studies and the previously described en-
hancement of antibody-mediated tissue injury by concomitant
adjuvant therapy [40—42] suggest that such a modulating func-
tion by humoral immune mediators, as described for endothelial
and some epithelial cells in culture, may indeed occur in the
intact animal.
Such a synergism between antibodies and soluble immune
mediators has recently been described for antibody-mediated
cell injury following the exposure of cultured endothelium to sera
obtained during the active phase from patients with Kawasaki's
syndrome [63, 64]. These studies clearly demonstrate that the
endothelial target antigens for the circulating antibodies present
in such patients are only induced following the exposure of the
cultures to IL-I, TNF, or IFN-y. Cell lysis was not induced by
these sera on untreated endothelial cells that had not undergone
the phenotypic modulation.
The glomerular abnormalities reported here are similar to
those seen in models of minimal change disease including the
proteinuric states induced in the rat by the administration of
epithelial toxins such as puromycin aminonucleoside or adria-
mycin [65-68]. However, in contrast to these experimental
models, the pathologic process induced by monoclonal anti-
body K9/9 is brief and reversible. We postulate that the
antibody interferes directly with the normal function of its
specific cell surface antigen or a closely associated cell mem-
brane constituent, an interaction that may result in the observed
alterations in epithelial cell shape and adhesion. These struc-
tural abnornalities are particularly pronounced and lead to overt
proteinuria only in animals exposed to a strong immune chal-
lenge. The nature of the interaction between monoclonal anti-
body K9/9 and its target antigen, the ensuing alterations at the
cellular level, and the mechanism of the potentiating effect of
adjuvant therapy on this interaction remain to be clarified.
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